Last reviewed · How we verify
Brown, Theodore R., M.D., MPH — Portfolio Competitive Intelligence Brief
2 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| dalfampridine ER | dalfampridine ER | marketed | ||||
| Anesthetic Topical Adhesive Synera | Anesthetic Topical Adhesive Synera | marketed | Topical local anesthetic | Voltage-gated sodium channels | Anesthesia/Pain Management |
Therapeutic area mix
- Anesthesia/Pain Management · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- American University of Beirut Medical Center · 1 shared drug class
- Eugene Y Rhee, MD · 1 shared drug class
- IWK Health Centre · 1 shared drug class
- The University of Texas Health Science Center, Houston · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Brown, Theodore R., M.D., MPH:
- Brown, Theodore R., M.D., MPH pipeline updates — RSS
- Brown, Theodore R., M.D., MPH pipeline updates — Atom
- Brown, Theodore R., M.D., MPH pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Brown, Theodore R., M.D., MPH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/brown-theodore-r-m-d-mph. Accessed 2026-05-18.